The company’s Q3FY25 EBITDA zoomed 78.2% YoY to ₹117.8 crore. The EBITDA margin expanded significantly to 38.4% versus 30.1% a year ago. Shares of Suven Pharmaceuticals Ltd ended at ₹1,050.10, down by ₹33.05, or 3.05%, on the BSE.
The company’s Q3FY25 EBITDA zoomed 78.2% YoY to ₹117.8 crore. The EBITDA margin expanded significantly to 38.4% versus 30.1% a year ago. Shares of Suven Pharmaceuticals Ltd ended at ₹1,050.10, down by ₹33.05, or 3.05%, on the BSE.